Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease
Shailendra KapoorRichmond, VA, USATo the editorI read with great interest the recent article by Barasch et al in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen the emergence of a number of novel clinical applications of palifermin...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59b019fc9823447abef1f68dff578e63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:59b019fc9823447abef1f68dff578e63 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:59b019fc9823447abef1f68dff578e632021-12-02T01:50:51ZEmerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease1177-54751177-5491https://doaj.org/article/59b019fc9823447abef1f68dff578e632012-06-01T00:00:00Zhttp://www.dovepress.com/emerging-new-clinical-applications-for-palifermin-beyond-its-use-in-or-a10049https://doaj.org/toc/1177-5475https://doaj.org/toc/1177-5491Shailendra KapoorRichmond, VA, USATo the editorI read with great interest the recent article by Barasch et al in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen the emergence of a number of novel clinical applications of palifermin, in addition to its use in oral mucositis and graft versus host disease.  Kapoor SDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2012, Iss default, Pp 135-136 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Kapoor S Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
description |
Shailendra KapoorRichmond, VA, USATo the editorI read with great interest the recent article by Barasch et al in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen the emergence of a number of novel clinical applications of palifermin, in addition to its use in oral mucositis and graft versus host disease.   |
format |
article |
author |
Kapoor S |
author_facet |
Kapoor S |
author_sort |
Kapoor S |
title |
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
title_short |
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
title_full |
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
title_fullStr |
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
title_full_unstemmed |
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
title_sort |
emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
https://doaj.org/article/59b019fc9823447abef1f68dff578e63 |
work_keys_str_mv |
AT kapoors emergingnewclinicalapplicationsforpaliferminbeyonditsuseinoralmucositisandgraftversushostdisease |
_version_ |
1718402838120366080 |